Ekso Bionics Holdings Inc
NASDAQ:EKSO

Watchlist Manager
Ekso Bionics Holdings Inc Logo
Ekso Bionics Holdings Inc
NASDAQ:EKSO
Watchlist
Price: 8.39 USD -1.29% Market Closed
Market Cap: $28.4m

Net Margin

-72.3%
Current
Improving
by 9.5%
vs 3-y average of -81.7%

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-72.3%
=
Net Income
$-10.7m
/
Revenue
$14.7m

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-72.3%
=
Net Income
$-10.7m
/
Revenue
$14.7m

Peer Comparison

Country Company Market Cap Net
Margin
US
Ekso Bionics Holdings Inc
NASDAQ:EKSO
28.4m USD
Loading...
US
Abbott Laboratories
NYSE:ABT
190.1B USD
Loading...
US
Intuitive Surgical Inc
NASDAQ:ISRG
181.4B USD
Loading...
US
Stryker Corp
NYSE:SYK
140.5B USD
Loading...
US
Boston Scientific Corp
NYSE:BSX
139.4B USD
Loading...
IE
Medtronic PLC
NYSE:MDT
131.6B USD
Loading...
US
Becton Dickinson and Co
NYSE:BDX
58.1B USD
Loading...
DE
Siemens Healthineers AG
XETRA:SHL
47.2B EUR
Loading...
US
IDEXX Laboratories Inc
NASDAQ:IDXX
54.1B USD
Loading...
US
Edwards Lifesciences Corp
NYSE:EW
47.4B USD
Loading...
US
Resmed Inc
NYSE:RMD
37.1B USD
Loading...

Market Distribution

Lower than 83% of companies in the United States of America
Percentile
17th
Based on 15 072 companies
17th percentile
-72.3%
Low
-4 418 600% — -9.6%
Typical Range
-9.6% — 11.3%
High
11.3% — 1 135 400%
Distribution Statistics
the United States of America
Min -4 418 600%
30th Percentile -9.6%
Median 3.1%
70th Percentile 11.3%
Max 1 135 400%

Ekso Bionics Holdings Inc
Glance View

Market Cap
28.4m USD
Industry
Health Care

Ekso Bionics Holdings, Inc. engages in the design, development and sale of exoskeleton technology that currently has applications in healthcare and industrial markets. The company is headquartered in Richmond California, California and currently employs 45 full-time employees. The company went IPO on 2013-04-10. The Company’s exoskeleton technology serves multiple markets and can be utilized both by able-bodied users and persons with physical disabilities. The firm operates in two segments: EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, and markets exoskeleton devices to allow able-bodied users to perform repetitive work. Its products include EksoNR and EksoUE. EksoNR is a rehabilitation device that assists physical therapists and physicians to treat patients who have suffered an acquired brain injury, stroke or spinal cord injury. EksoUE is a wearable upper body exoskeleton that assists patients with a broad range of upper extremity impairments.

EKSO Intrinsic Value
12.45 USD
Undervaluation 33%
Intrinsic Value
Price
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
-72.3%
=
Net Income
$-10.7m
/
Revenue
$14.7m
What is Ekso Bionics Holdings Inc's current Net Margin?

The current Net Margin for Ekso Bionics Holdings Inc is -72.3%, which is above its 3-year median of -81.7%.

How has Net Margin changed over time?

Over the last 3 years, Ekso Bionics Holdings Inc’s Net Margin has increased from -112.6% to -72.3%. During this period, it reached a low of -116.8% on Dec 31, 2022 and a high of -62.8% on Mar 31, 2025.

Back to Top